About Us
Our Company
Leadership
Compliance
Contact
Medical Education Grants
Our
Medicines
YCANTH
Product
Candidates
Pipeline VP-102
Pipeline VP-103
Pipeline VP-315
R & D
Key Publications
Investors &
Media
Investor Overview
Press Releases
Analyst Coverage
Presentations & Events
Stock Information
SEC Filings
Corporate Governance
Investor FAQs
Investor Connection
Careers
Menu
About Us
Our Company
Leadership
Compliance
Contact
Medical Education Grants
Our
Medicines
YCANTH
Product
Candidates
Pipeline VP-102
Pipeline VP-103
Pipeline VP-315
R & D
Key Publications
Investors &
Media
Investor Overview
Press Releases
Analyst Coverage
Presentations & Events
Stock Information
SEC Filings
Corporate Governance
Investor FAQs
Investor Connection
Careers
For information about YCANTHâ„¢ or to request a representative, visit YCANTHPro.com
SEC Filing Group:
Other
0001193125-21-016443
159-EFFECT -20200325
147-SC 13G/A -20200214
146-SC 13G/A -20200203
145-SC 13G/A -20200130
86-SC 13G -20190404
66-SC 13G/A -20190214
63-SC 13G -20190206
46-CT ORDER -20181217
30-SC 13G -20180802
←
older
newer
→